Article Details
Retrieved on: 2018-04-10 18:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Aetion, a NYC-based software platform company delivering real-world analytics and evidence to biopharma and payers, raised $36.4m in Series B funding. The round was led by <b>New Enterprise Associates</b> (NEA) with participation fro new investor Amgen Ventures and existing investors Flare Capital ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here